Optical Coherence Tomography Angiography in Myopic Patients
Evaluation of Macular Microvasculature in High Myopia Using Optical Coherence Tomography Angiography
1 other identifier
observational
55
1 country
1
Brief Summary
The aim of this study is to investigate the macular microvascular network alterations in high myopic eyes using optical coherence tomography angiography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2019
CompletedFirst Submitted
Initial submission to the registry
October 12, 2019
CompletedFirst Posted
Study publicly available on registry
October 22, 2019
CompletedOctober 22, 2019
October 1, 2019
1 year
October 12, 2019
October 19, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in angiography between the 2 groups
The difference of the volumetric data generated automatically from the OCTA machine at the 3 levels, (the inner retina, outer retina and the choriocapillaris) in three zones (the fovea, the parafovea and the whole image)
through study completion, an average of 4 weeks
Study Arms (2)
Healthy controls
Healthy individuals of age-matched
Myopic patients
Patients with myopia who meet the inclusion criteria
Interventions
Macular scanning using regular structural OCT as well as microvasculature analysis using OCTA
Eligibility Criteria
Groiup A patients were chosen when met the inclusion criteria. Group B individuals were chosen among healthy age-matched controls.
You may qualify if:
- Highly myopic subjects, defined as those with spherical equivalents (SEs) of -6 or more, with axial length greater than 26.5 mm.
- Group B individuals were chosen among healthy age-matched controls.
You may not qualify if:
- Patients younger than 18 years old, or older than 45 years.
- Any patient with macular pathology (e.g. diabetic retinopathy, hypertensive retinopathy, dystrophy)
- Myopic patients with any vitro-retinal abnormalities (e.g. choroidal neovascular membrane (CNVM), foveoschisis,macular hole)
- Patients who underwent previous intra ocular surgical procedures.
- Patients with previous history of intraocular injections.
- Glaucomatous patients.
- \- Low signal strength index (less than 50).
- \- Presence of blink artefacts.
- \- Poor fixation leading to motion or doubling artefacts.
- \- Media opacity obscuring view of the vasculature.
- \- Segmentation error due to cystoid macular oedema or epi-retinal membrane, among others.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Minia Universitylead
Study Sites (1)
Minia University
Minya, Minya Governorate, 61111, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
M. Tarek A Mosutafa, MD
Lecturer of ophthalmology
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Ophthalmology
Study Record Dates
First Submitted
October 12, 2019
First Posted
October 22, 2019
Study Start
January 1, 2018
Primary Completion
January 1, 2019
Study Completion
June 1, 2019
Last Updated
October 22, 2019
Record last verified: 2019-10